Disease | meningitis |
Phenotype | C0242379|lung cancer |
Sentences | 2 |
PubMedID- 24649247 | Recently, the benefits of egfr-tkis in the treatment of carcinomatous meningitis in patients with non-small-cell lung cancer (nsclc) have attracted attention, although all studies were case reports or case series (2–8). |
PubMedID- 22679236 | The treatment of carcinomatous meningitis in patients with non-small cell lung cancer is unsatisfactory with a median survival ranging from 4 to 6 weeks without treatment. |
Page: 1